| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Common shares without par value | 82,123 | $8,891,457 | $108.27 | 24 Feb 2026 | Direct |
| ABBOTT LABORATORIES | EXECUTIVE VICE PRESIDENT | Option (right to buy) | 76,273 | 24 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24 Feb 2026 | 2 | $0 | 4 | EXECUTIVE VICE PRESIDENT | 26 Feb 2026, 19:15 |
| ABT | ABBOTT LABORATORIES | 12 Dec 2025 | 0 | $0 | 3 | EXECUTIVE VICE PRESIDENT | 19 Dec 2025, 16:39 |